Synairgen signs collaboration agreement with Cambridge Antibody TechnologyOctober 13th, 2022
FiledOctober 13th, 2022Cambridge Antibody Technology (CAT) and Synairgen Ltd of Southampton have entered into a research contract involving CAT's novel anti IL-13 antibody, CAT-